Morgan Stanley raised the firm’s price target on Align Technology (ALGN) to $188 from $169 and keeps an Equal Weight rating on the shares. The firm’s U.S. dental survey suggests softer practice volume across Q1, but the Specialty segment, including clear aligner and implant, demand improved slightly, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology price target raised to $235 from $220 at Piper Sandler
- Cloudflare upgraded, SolarEdge downgraded: Wall Street’s top analyst calls
- Align Technology initiated with a Buy at Citi
- Align Technology added to ‘Tactical Outperform’ list at Evercore ISI
- Early notable gainers among liquid option names on March 19th